Amy K Johnson
Overview
Explore the profile of Amy K Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corcoran J, McDonald V, Hahn A, Singer R, Kempf M, Schnall R, et al.
AIDS Patient Care STDS
. 2025 Mar;
PMID: 40082074
In 2022, cisgender women accounted for one in five HIV diagnoses in the United States. Existing structural, social, and behavioral factors impede women's engagement with HIV prevention strategies including Pre-Exposure...
2.
Johnson A, Ott E, Friedman E, Pandiani A, Moore A, Alvarez I, et al.
BMJ Public Health
. 2025 Feb;
3(1):e000809.
PMID: 40017987
Background: Despite pre-exposure prophylaxis (PrEP) demonstrated effectiveness, black cisgender women continue to be at an elevated risk for HIV acquisition and uptake of daily oral PrEP is low in this...
3.
Xiao F, Johnson A, Kempf M, Hughes T, Kenniff J, Klitzman R, et al.
AIDS Patient Care STDS
. 2025 Jan;
39(2):33-35.
PMID: 39873658
No abstract available.
4.
Kozhumam A, Singh R, Agbaji O, Adetunji A, Taiwo B, Omigbodun O, et al.
Implement Sci Commun
. 2025 Jan;
6(1):6.
PMID: 39780298
Background: Youth living with HIV (YLH) are disproportionately impacted by HIV with poor outcomes along the entire HIV care continuum. In a 2020-2022 pilot study, iCARE Nigeria, successfully tested a...
5.
Schnall R, Kempf M, Phillips 2nd G, Dionne J, Wingood G, Long D, et al.
BMC Public Health
. 2024 Dec;
24(1):3422.
PMID: 39695485
Background: While progress has been made in reducing HIV incidence rates among cisgender women, it continues to fall short of reaching the goal of ending the HIV epidemic with no...
6.
Liegeon G, Devlin S, Manda V, Castaneda J, Marsh C, Ridgway J, et al.
AIDS Patient Care STDS
. 2024 Nov;
38(11):507-516.
PMID: 39565725
Women who have migrated from sub-Saharan Africa (SSA) are underrepresented among HIV pre-exposure prophylaxis (PrEP) users in France (∼2%), yet they account for around 20% of new HIV infections annually....
7.
Johnson A, Devlin S, Pyra M, Etshokin E, Ducheny K, Friedman E, et al.
JMIR Form Res
. 2024 Nov;
8():e59800.
PMID: 39546769
Background: Black cisgender women (hereafter referred to as "women") experience one of the highest incidences of HIV among all populations in the United States. Pre-exposure prophylaxis (PrEP) is an effective...
8.
Johnson A, Devlin S, Hill M, Ott E, Friedman E, Haider S
Healthcare (Basel)
. 2024 Sep;
12(17).
PMID: 39273793
Black women continue to be disproportionally burdened by HIV. Pre-exposure prophylaxis (PrEP) is an effective HIV prevention option, which is underused by Black women. While social network interventions (SNIs) have...
9.
Kasal N, Devlin S, Johnson A, Dawdani A, Enaholo O, Liegeon G, et al.
Womens Health (Lond)
. 2024 Sep;
20:17455057241277974.
PMID: 39245949
Background: Awareness and uptake of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) remains low among Black/African American cisgender women, partly due to low self-reported PrEP knowledge and comfort among primary...
10.
Kuhns L, Perloff J, Johnson A, Paul J, Pleasant K, Evans K, et al.
AIDS Educ Prev
. 2024 Jun;
36(3):155-167.
PMID: 38917300
Transgender women are disproportionately impacted by HIV infection. We report herein the findings of a pre-post evaluation of the TransLife Care (TLC) project in Chicago, Illinois, on behaviors associated with...